RBC membrane camouflaged boron nitride nanospheres for enhanced biocompatible performance
Source abstract
Abstract
Boron nitride nanospheres (BNNS) have attracted increasing attention in many fields due to their unique physicochemical properties. Biomedical application of BNNS has also been explored recently. However, limited by the hydrophobicity and poor dispersity of BNNS, their biocompatible performance especially the in vivo biosafety has rarely been reported and is still unclear now. In this work, BNNS were firstly camouflaged with red blood cell membrane by physical extrusion (CM-BNNS). CM-BNNS were then incubated with cells as well as intravenously injected into the mice to uncover their potential in vitro and in vivo toxicity. Results were promising as CM-BNNS exhibited better dispersion and stability compared with pristine BNNS. In vitro data demonstrated the relatively enhanced biosafety of CM-BNNS. The red blood cell membrane coating endowed BNNS with markedly prolonged blood circulation and decreased accumulation in the lung. In addition, CM-BNNS showed no adverse effects on all the evaluated hematic parameters and tissues of treated mice at a dose of 10 mg/kg. Taken together, our work demonstrated the optimal biocompatibility of CM-BNNS and pave the way for their future biomedical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Nanoparticles in cancer therapy and diagnosis10.1016/j.addr.2012.09.006 ↗
2. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
3. Emerging nanotechnology and advanced materials for Cancer radiation therapy10.1002/adma.201700996 ↗
4. Luminescent nanoswitch based on organic-phase copper nanoclusters for sensitive detection of trace amount of water in organic solvents10.1021/acs.analchem.6b02149 ↗
5. Dual-emission of lanthanide metal-organic frameworks encapsulating carbon-based dots for ratiometric detection of water in organic solvents10.1021/acs.analchem.5b03974 ↗
6. Photoluminescent carbon dots directly derived from polyethylene glycol and their application for cellular imaging10.1016/j.carbon.2014.01.016 ↗
7. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
8. Impact of nanotechnology on drug delivery10.1021/nn900002m ↗
9. Boron nitride nanotubes: an innovative tool for nanomedicine10.1016/j.nantod.2008.09.001 ↗
10. Boron nitride nanotubes and nanosheets10.1021/nn1006495 ↗
11. Nano boron nitride flatland10.1039/C3CS60260E ↗
12. Boron nitride nanotubes10.1002/adma.200700179 ↗
13. Hexagonal boron nitride-graphene heterostructures: synthesis and interfacial properties10.1002/smll.201501766 ↗
14. Hexagonal boron nitride nanoplates as emerging biological nanovectors and their potential applications in biomedicine10.1039/C6TB01481J ↗
15. Functionalized hexagonal boron nitride nanomaterials: emerging properties and applications10.1039/C5CS00869G ↗
16. Boron neutron capture therapy of cancer: current status and future prospects10.1158/1078-0432.CCR-05-0035 ↗
17. Engineering novel targeted Boron-10-Enriched theranostic nanomedicine to combat against murine brain tumors via MR imaging-guided boron neutron capture therapy10.1002/adma.201700850 ↗
18. Nanostructured boron nitride with high water dispersibility for boron neutron capture therapy10.1038/srep35535 ↗
19. Application of drug delivery system to boron neutron capture therapy for cancer10.1517/17425247.5.4.427 ↗
20. Recent advancements in boron nitride nanotubes10.1039/c0nr00335b ↗
21. Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery10.1021/nn5014808 ↗
22. Boron nitride nanostructures: fabrication, functionalization and applications10.1002/smll.201600053 ↗
23. Boron nitride nanotubes: recent advances in their synthesis, functionalization, and applications10.3390/molecules21070922 ↗
24. Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment
25. Boron nitride nanoparticles with a petal-like surface as anticancer drug-delivery systems, ACS Appl10.1021/acsami.5b04101 ↗
26. Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells10.1021/ja807334b ↗
27. Fe3O4 nanoparticle-coated boron nitride nanospheres: synthesis, magnetic property and biocompatibility study10.1016/j.ceramint.2017.02.047 ↗
28. Assessing cytotoxicity of boron nitride nanotubes: interference with the MTT assay10.1016/j.bbrc.2010.03.035 ↗
29. Pilot in vivo toxicological investigation of boron nitride nanotubes10.2147/IJN.S28144 ↗
30. Biocompatibility of boron nitride nanotubes: an up-date of in vivo toxicological investigation10.1016/j.ijpharm.2013.01.037 ↗
31. Folate functionalized boron nitride nanotubes and their selective uptake by glioblastoma multiforme cells: implications for their use as boron carriers in clinical boron neutron capture therapy10.1007/s11671-008-9210-9 ↗
32. Safety assessment of boron nitride as used in cosmetics10.1177/1091581815617793 ↗
33. Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines
34. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides10.2147/IJN.S88774 ↗
35. The hollow fiber model: a new method for in vivo-evaluation of antitumor effect, toxicity and pharmacokinetics of new anticancer drugs
36. BN nanospheres as CpG ODN carriers for activation of toll-like receptor 910.1039/c1jm10199d ↗
37. Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides10.1039/c2nr31189e ↗
38. Folate-conjugated, mesoporous silica functionalized boron nitride nanospheres for targeted delivery of doxorubicin10.1016/j.msec.2018.11.063 ↗
39. Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs10.2147/IJN.S110689 ↗
40. pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery10.2147/IJN.S153476 ↗
41. Perfectly dissolved boron nitride nanotubes due to polymer wrapping10.1021/ja053917c ↗
42. Boron nitride nanotubes functionalized with mesoporous silica for intracellular delivery of chemotherapy drugs10.1039/c3cc42743a ↗
43. Functionalization, Dispersion, and Cutting of Boron Nitride Nanotubes in Water10.1021/jp2112999 ↗
44. Effect of polyethylene glycol on gene delivery of polyethylenimine10.1248/bpb.26.492 ↗
45. Surface functionalization of gold nanoparticles with red blood cell membranes10.1002/adma.201300638 ↗
46. Cell-based drug delivery and use of nano- and microcarriers for cell functionalization
47. Long circulation red-blood-Cell-Mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast Cancer10.1002/adfm.201504780 ↗
48. Converting red blood cells to efficient microreactors for blood detoxification
49. Synthetic routes and formation mechanisms of spherical boron nitride nanoparticles10.1002/adfm.200800493 ↗
50. The protective study about alleviation of simvastatin on the damages of PEG-BNs in mice10.1016/j.etap.2017.04.021 ↗